CAR-Immunotherapy PUBLISHED RESULTS
The CAR-Immunotherapy results file contains 12 parameters for 89 full papers, and lists 28 case reports, published through 30 June 2019.
For each publication, the following topics are covered:
- Trial ID
- Publication ID and link
- First/ last author and year of report
- CAR target
- Trial endpoints
- Number of patients (enrolled, infused, evaluable)
- Safety/ adverse events data
- Efficacy data
- CAR cells persistence in vivo
- Durability of response
- Were endpoints met?
Release 6 covers publications through 30 June 2019.
- Total number of full papers increases by 8 from 81 to 89 publications.
- 8 publications added (6 in liquid and 2 in solid malignancies)
- 4 clinical cases added
one trial ID was not disclosed in publication
one trial has two IDs
Release 5 covers publications up to 31 Dec. 2018.
- Total number of full papers increases by 12 from 69 to 81 publications.
- 9 trials added
- 9 publications added
- 3 publications IDs (PMID) added to existent data (new papers analyzed different aspects of the same trial)
- 2 clinical cases added
Release 4 covers publications up to 31 July 2018, including 9 full papers published in the first half of 2018.
- 2 trial results were updated for liquid malignancies with data from the most recent publications (2018)
- 4 more trials and 5 new full papers (one trial was not registered) were added to liquid malignancies
- 2 more trials and 2 new full papers were added to solid malignancies
- 4 more clinical case reports added (second tab)
- changes from the previous update are highlighted in green
|SAMPLE CAR-immunotherapy Publications||10.4 KB|